The univariate analysis demonstrated that five clinical factors were associated with PFS and OS (P < 0.1); these factors were increased LDH level, thrombocytopenia, low serum albumin level, high serum β2-microglobulin and non-CR after front-line treatment. The gene discussed is HLA-G; the disease is Thrombocytopenia.